# The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt

> **NCT07218536** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 200 (estimated)

## Conditions studied

- Atypical Hemolytic Uremic Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07218536
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-13
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07218536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07218536, "The Burden of Atypical Hemolytic Uremic Syndrome and The Clinical Characteristics of Patients in Egyptian Hospitals A Multicenter, Observational, Retrospective Cohort Study in Egypt". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07218536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*